AzTrials
AzTrials

Respiratory FailureLOVE BEERNCT06174636

Lung Overdistension and Abdominal Pressure Rise

A study testing Application of abdominal weight in people with Respiratory Failure and Respiratory Distress Syndrome, Adult, run by University of Padova at 1 site in Italy.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The goal of this pilot interventional no-profit study is to evaluate airway pressure, esophageal pressure and variations in lung volume distribution with EIT in mechanically ventilated patients admitted to our UTI with respiratory failure after the application of an abdominal weight and resulting increase of… Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Application of abdominal weight
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteItaly
Study dates
20 Jun 2023to Jun 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Invasive mechanical ventilation in acute respiratory failure (PaO2/FiO2 <300 mmHg)
  • Need of PEEP trial
  • Need of urinary catheter (used to measure IAP)

Who cannot join

  • Contraindication to EIT use
  • Pacemaker or other metal device in thoracic region
  • Contraindication to abdominal weight placement
  • Surgical or traumatic incision on the abdomen
  • Severe abdominal hypertension
  • Esophageal diseases that counterindicate naso-gastric tube placement
Show all 9Show fewer
  • Severe hemodynamic instability (norepinephrine > 0.1 mcg/kg/min; dobutamine or dopamine > 5 mcg/kg/min; epinephrine every dosage)
  • Severe obesity (BMI > 35 kg/m2)
  • Need of > 7 kg weight to reach 5 mmHg IAP increase

Trial locations and contacts

1 site in 1 country.

Paolo Persona, MD, PhD contact

+39 3389745902

ppersona75@gmail.com

Italy1 site, 1 recruiting
  • Azienda Ospedaliera Università di Padova

    Padova, 35100

    Paolo Persona, MD, 00390498212222, ppersona75@gmail.com

    Recruiting

Other trials in Italy

About this study

Official title: Lung Overdistension and Abdominal Pressure Rise: an EIT Based Pilot Study

The goal of this pilot interventional no-profit study is to evaluate airway pressure, esophageal pressure and variations in lung volume distribution with EIT in mechanically ventilated patients admitted to our UTI with respiratory failure after the application of an abdominal weight and resulting increase of intra-abdominal pressure.

Being tested
Application of abdominal weight
Keywords
Abdominal pressure, Overdistension
Medical subject headings
Respiratory Insufficiency, Respiratory Distress Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Application of abdominal weightProcedure or surgery

    Also called Intra abdominal pressure rise

    Application of variable weight on the abdomen to reach a 5 mmHg increase in IAP

Study groups in NCT06174636
Study groupRoleWhat they receive
Abdominal Pressure RiseExperimentalApplication of an abdominal weight and record of respiratory mechanics data, intra-abdominal pressure variation, Electrical Impedance Tomography data
Receives: Procedure: Application of abdominal weight

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Variation of lung volume distribution

    TID %

    Measured: through study completion, an average of 1 year

  2. Variation of airway pressure

    cmH2O

    Measured: through study completion, an average of 1 year

  3. Variation of esophageal pressure

    cmH2O

    Measured: through study completion, an average of 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Dec 2023
  2. Study start20 Jun 2023
  3. Primary completionJun 2025 (estimated)
  4. Study completionJun 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06174636
Sponsor's protocol ID
AOP2978
Acronym
LOVE BEER
Status last verified
Dec 2023
First submitted
9 Jul 2023
Last updated
18 Dec 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Pacchiarini G, Pettenuzzo T, Zarantonello F, Sella N, Lumetti G, Boscolo A, De Cassai A, Cammarota G, Persona P, Navalesi P; LOVE BEER Study Group. The "mechanical paradox" unveiled: a physiological study. Crit Care. 2025 May 16;29(1):194. doi: 10.1186/s13054-025-05385-9.

    PubMed 40380228

Questions about this trial

What is this clinical trial studying?

A study testing Application of abdominal weight in people with Respiratory Failure and Respiratory Distress Syndrome, Adult, run by University of Padova at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 18 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Paolo Persona, MD, PhD (+39 3389745902, ppersona75@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Variation of lung volume distribution (time frame: through study completion, an average of 1 year). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06174636, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Dec 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in